AMERICAN BIOMED, Minimally Invasive Technology (ABMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jeffrey L. Henken who wrote (471)	4/14/1998 9:33:00 PM
From: Aishwarya	Read Replies (1) of 2887

Jeff, Thanks a lot for your work in keeping the the thread fine tuned with the developments in this area in the past few days. One interesting observation that you did not miss was the narrow line of products World medical manufacturing has to offer in return for the 64 mil dollars in return. Only about 5 products and i cannot verify if any are FDA approved. Now lets get back to ABMI: They have over 25 patents 10 FDA approved products. More product ideas are also existing which are sitting on the shelf due to the pitfall in R&D like Defibrillators etc. Now a company that would look at ABMI as a prospective candidate will have to peruse through a lot more research and a lot more products to evaluate. By default if $3 is a figure paid per share it still adds up to less than 60 mil. The company is worth a lot more than that. That is why it is a severely undervalued company and if a few more OEM deals come our way this company will be on a rocket trajectory and all who got in below the .99 price a few days ago will reap huge rewards. Here check the website for world medical manufacturing for yourselves medicom.com Now compare the extensive line of products ABMI has developed americanbiomed.com I think we are in the right place at the right time. The trend will change when others see the facts and buy based on potential. the risk factor is a lot lower even though it is a BB stock. AVEI is at 37 with a possibility of doubling within a year. But there is a lot of downside to it in the sense to compete with JNJ and other well managed companies like Boston Scientific they will have to be on a warpath for acquiring other companies and stay ahead of the competition. Just thoughts, Sri.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next